Reducing the burden of cancer requires rapid translation of research breakthroughs into clinical therapies—and that requires specifically trained cancer scientists.
Our new doctoral program in Translational Cancer Biology trains investigators not only in fundamental research, but also innovative fields like precision genomics, immunotherapy, drug development and screening, data science, and more.
Our PhD in Translational Cancer Biology is student-centered, workforce-aligned, and future-focused. Because we know that #ResearchCuresCancer.
Recent advances in genomics have revolutionized our understanding of cancer, but we need more cancer scientists to translate these findings into clinical practice.
Hari Nakshatri, PhD — Associate Director for Education
You'll complete course work and conduct research on wide range of cancer topics, including:
According to the U.S. Bureau of Labor Statistics, expected job growth for medical scientists between 2020 and 2030 is 17 percent.
Our integrated training will guide you through not only basic science courses, but also clinical and translational research projects through the diverse research activities of cancer center members.
Your faculty mentors—aligned with our four key research programs—will support you in becoming an outstanding scientist ready to excel in academic, clinical, and industrial biomedical research.
Because cancer science is a dynamic field with an ever-expanding array of new technologies and innovations, we’ll continually update courses to incorporate the latest breakthroughs in cancer research and treatment.
You'll learn in an academic setting where world-renowned laboratory research and clinical care take place side by side.
This program is open to candidates from any background irrespective of race, ethnicity, socioeconomic status, or geographic location as long as the candidate meets the eligibility requirements for an undergraduate degree.
Selection of candidates will consider not only academic performance, but also NIH-defined criteria for underrepresented populations. Representatives from the cancer center’s Diversity, Equity and Inclusion team will participate in candidate selection.
